Dedicated to our Patients and Changing the Future of Oncology.

Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience.
Take a Closer Look at the Promise of Our iADC Next-Gen Technology

Our Technology Not Only Kills The Tumor But Also Elicits Immunogenic Cell Death

Our innovative Research and development has resulted in six product candidates

Our Pipeline

Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies and cytokine derivatives targeting immuno-oncology pathways.

Proud Winner

2024 BioSpace
Best Places to Work

Sutro is honored to be named, BioSpace Best Places to Work for 2024. Many thanks to our Sutro team for their continuous efforts in placing our patients first. We appreciate and value all the work you have done!

To read the report, click the link .

 

Diversity, Equity, Inclusion and Belonging (DEIB)

Our Commitment to Change.

Sutro Biopharma has partnered with California Life Sciences Association (CLSA) to create a more diverse industry to spark solutions for a better healthier world. CLSA members have raised $1M with a goal of sustaining 3-year commitments of $1M annually for Racial & Social Equity Initiative We Commit To Change

Collaborating with Local Community Organizations

Together, we can make a difference

CuriOdyssey

La Casa de Las Madres

St. Anthony’s Padua Dining Room

Homeless Prenatal Program

Peninsula Bridge

Students Rising Above

Korn Ferry

Peninsula Post Acute

Sunshine Gardens Elementary School

Sign Up for Email Alerts